Literature DB >> 29897597

High-Frequency Neuronavigated rTMS in Auditory Verbal Hallucinations: A Pilot Double-Blind Controlled Study in Patients With Schizophrenia.

Sonia Dollfus1,2, Nemat Jaafari3,4, Olivier Guillin5,6,7, Benoit Trojak8, Marion Plaze9, Ghassen Saba10, Cécilia Nauczyciel11, Aurélie Montagne Larmurier1, Nathalie Chastan7, Vincent Meille8, Marie-Odile Krebs9, Samar S Ayache12, Jean Pascal Lefaucheur12, Annick Razafimandimby2, Elise Leroux2, Rémy Morello13, Jean Marie Batail11, Perrine Brazo1,2, Nicolas Lafay3, Issa Wassouf3, Ghina Harika-Germaneau3, Remy Guillevin7, Carole Guillevin7, Emmanuel Gerardin7, Maud Rotharmel5, Benoit Crépon14, Raphael Gaillard9, Christophe Delmas5, Gael Fouldrin7, Guillaume Laurent5, Clément Nathou1,2,5, Olivier Etard2,15.   

Abstract

INTRODUCTION: Despite extensive testing, the efficacy of low-frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) of temporo-parietal targets for the treatment of auditory verbal hallucinations (AVH) in patients with schizophrenia is still controversial, but promising results have been reported with both high-frequency and neuronavigated rTMS. Here, we report a double-blind sham-controlled study to assess the efficacy of high-frequency (20 Hz) rTMS applied over a precise anatomical site in the left temporal region using neuronavigation.
METHODS: Fifty-nine of 74 randomized patients with schizophrenia or schizoaffective disorders (DSM-IV R) were treated with rTMS or sham treatment and fully evaluated over 4 weeks. The rTMS target was determined by morphological MRI at the crossing between the projection of the ascending branch of the left lateral sulcus and the superior temporal sulcus (STS).
RESULTS: The primary outcome was response to treatment, defined as a 30% decrease of the Auditory Hallucinations Rating Scale (AHRS) frequency item, observed at 2 successive evaluations. While there was no difference in primary outcome between the treatment groups, the percentages of patients showing a decrease of more than 30% of AHRS score (secondary outcome) did differ between the active (34.6%) and sham groups (9.1%) (P = .016) at day 14. DISCUSSION: This controlled study reports negative results on the primary outcome but demonstrates a transient effect of 20 Hz rTMS guided by neuronavigation and targeted on an accurate anatomical site for the treatment of AVHs in schizophrenia patients.

Entities:  

Mesh:

Year:  2018        PMID: 29897597      PMCID: PMC5890503          DOI: 10.1093/schbul/sbx127

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  61 in total

Review 1.  Is there a future for therapeutic use of transcranial magnetic stimulation?

Authors:  Michael C Ridding; John C Rothwell
Journal:  Nat Rev Neurosci       Date:  2007-07       Impact factor: 34.870

2.  Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?

Authors:  Romain Duprat; Stefanie Desmyter; De Raedt Rudi; Kees van Heeringen; Dirk Van den Abbeele; Hannelore Tandt; Jasmina Bakic; Gilles Pourtois; Josefien Dedoncker; Myriam Vervaet; Sara Van Autreve; Gilbert M D Lemmens; Chris Baeken
Journal:  J Affect Disord       Date:  2016-04-19       Impact factor: 4.839

3.  Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations.

Authors:  Giorgio Chibbaro; Marco Daniele; Giovanna Alagona; Concetta Di Pasquale; Michele Cannavò; Vincenzo Rapisarda; Rita Bella; Giovanni Pennisi
Journal:  Neurosci Lett       Date:  2005-04-15       Impact factor: 3.046

Review 4.  Safety of rTMS to non-motor cortical areas in healthy participants and patients.

Authors:  Katsuyuki Machii; Daniel Cohen; Ciro Ramos-Estebanez; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2006-01-04       Impact factor: 3.708

5.  Long-term effects of repetitive transcranial magnetic stimulation on markers for neuroplasticity: differential outcomes in anesthetized and awake animals.

Authors:  Roman Gersner; Elena Kravetz; Jodie Feil; Gaby Pell; Abraham Zangen
Journal:  J Neurosci       Date:  2011-05-18       Impact factor: 6.167

6.  Placebo Response in Repetitive Transcranial Magnetic Stimulation Trials of Treatment of Auditory Hallucinations in Schizophrenia: A Meta-Analysis.

Authors:  Sonia Dollfus; Laurent Lecardeur; Rémy Morello; Olivier Etard
Journal:  Schizophr Bull       Date:  2015-06-18       Impact factor: 9.306

7.  Transcranial magnetic stimulation of Wernicke's and Right homologous sites to curtail "voices": a randomized trial.

Authors:  Ralph E Hoffman; Kun Wu; Brian Pittman; John D Cahill; Keith A Hawkins; Thomas Fernandez; Jonas Hannestad
Journal:  Biol Psychiatry       Date:  2013-02-26       Impact factor: 13.382

8.  Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia.

Authors:  Catarina Freitas; Felipe Fregni; Alvaro Pascual-Leone
Journal:  Schizophr Res       Date:  2009-01-11       Impact factor: 4.939

9.  Two-day treatment of auditory hallucinations by high frequency rTMS guided by cerebral imaging: a 6 month follow-up pilot study.

Authors:  A Montagne-Larmurier; O Etard; A Razafimandimby; R Morello; S Dollfus
Journal:  Schizophr Res       Date:  2009-06-07       Impact factor: 4.939

10.  Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression.

Authors:  Brian Martis; Danesh Alam; Sheila M Dowd; S Kristian Hill; Rajiv P Sharma; Cherise Rosen; Neil Pliskin; Eileen Martin; Valorie Carson; Philip G Janicak
Journal:  Clin Neurophysiol       Date:  2003-06       Impact factor: 3.708

View more
  10 in total

Review 1.  The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis.

Authors:  Rasmus Lorentzen; Tuan D Nguyen; Alexander McGirr; Fredrik Hieronymus; Søren D Østergaard
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-09

2. 

Authors:  Clément Dondé; Frédéric Haesebaert; Emmanuel Poulet; Marine Mondino; Jérôme Brunelin
Journal:  Can J Psychiatry       Date:  2019-12-13       Impact factor: 4.356

Review 3.  Investigational and Therapeutic Applications of Transcranial Magnetic Stimulation in Schizophrenia.

Authors:  Urvakhsh Meherwan Mehta; Shalini S Naik; Milind Vijay Thanki; Jagadisha Thirthalli
Journal:  Curr Psychiatry Rep       Date:  2019-08-13       Impact factor: 5.285

Review 4.  Repetitive Transcranial Magnetic Stimulation as a Therapeutic and Probe in Schizophrenia: Examining the Role of Neuroimaging and Future Directions.

Authors:  Stephen J Brandt; Halimah Y Oral; Carla Arellano-Bravo; Martin H Plawecki; Tom A Hummer; Michael M Francis
Journal:  Neurotherapeutics       Date:  2021-04-12       Impact factor: 7.620

5.  Theta-Burst Stimulation for Auditory-Verbal Hallucination in Very-Late-Onset Schizophrenia-Like Psychosis-A Functional Magnetic Resonance Imaging Case Study.

Authors:  Rebecca Zöllner; Anne-Friederike Hübener; Udo Dannlowski; Tilo Kircher; Jens Sommer; Maxim Zavorotnyy
Journal:  Front Psychiatry       Date:  2020-04-20       Impact factor: 4.157

Review 6.  Auditory verbal hallucinations in schizophrenia: current perspectives in brain stimulation treatments.

Authors:  Clément Nathou; Olivier Etard; Sonia Dollfus
Journal:  Neuropsychiatr Dis Treat       Date:  2019-07-24       Impact factor: 2.570

7.  COMT-Val158Met polymorphism modulates antipsychotic effects on auditory verbal hallucinations and temporal lobe gray matter volumes in healthy individuals-symptom relief accompanied by worrisome volume reductions.

Authors:  Chuanjun Zhuo; Langlang Cheng; Gongying Li; Yong Xu; Rixing Jing; Shen Li; Li Zhang; Xiaodong Lin; Chunhua Zhou
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

8.  Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial.

Authors:  Jerome Brunelin; Marine Mondino; Julie Haesebaert; Jerome Attal; Michel Benoit; Marie Chupin; Sonia Dollfus; Wissam El-Hage; Filipe Galvao; Renaud Jardri; Pierre Michel Llorca; Laurent Magaud; Marion Plaze; Anne Marie Schott-Pethelaz; Marie-Françoise Suaud-Chagny; David Szekely; Eric Fakra; Emmanuel Poulet
Journal:  Trials       Date:  2021-12-28       Impact factor: 2.279

9.  A unified model of shared brain structural alterations in patients with different mental disorders who experience own-thought auditory verbal hallucinations-A pilot study.

Authors:  Chuanjun Zhuo; Chunxiang Wang; Xueqin Song; Xuexin Xu; Gongying Li; Xiaodong Lin; Yong Xu; Hongjun Tian; Deguo Jiang; Wenqiang Wang; Chunhua Zhou
Journal:  Brain Behav       Date:  2020-04-18       Impact factor: 2.708

10.  High-frequency neuronavigated rTMS effect on clinical symptoms and cognitive dysfunction: a pilot double-blind, randomized controlled study in Veterans with schizophrenia.

Authors:  Heng Yong Guan; Jian Min Zhao; Ke Qiang Wang; Xiu Ru Su; Yan Fen Pan; Jin Ming Guo; Long Jiang; Yu Hong Wang; Hong Yu Liu; Shi Guang Sun; Hao Ran Wu; Yan Ping Ren; Han Song Geng; Xiao Wen Liu; Hui Jing Yu; Bao Chun Wei; Xi Po Li; Hanjing Emily Wu; Shu Ping Tan; Mei Hong Xiu; Xiang Yang Zhang
Journal:  Transl Psychiatry       Date:  2020-02-25       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.